/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | IGCIGC Pharma, Inc. |
|---|---|
| Last close | $0.29 |
| Change % | +1.74% |
| Market cap | $29M |
| P/E | — |
| Revenue | $1M |
| Rev growth (YoY) | -5.5% |
| Net income | $-7122000 |
| Net margin | -560.3% |
| EPS (diluted) | $-0.09 |
| Piotroski F-ScoreUNVALIDATED | 3 |
| Altman Z-ScoreUNVALIDATED | -14.80 |
| Beneish M-ScoreUNVALIDATED | -3.69 |
| Next earnings | rep. 07-15 |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Green = best in the row among the compared names. Educational only — not investment advice.